雏鸭铜中毒的实验观察

1日龄天府肉鸭健雏210只随机分为三组,分别喂给铜12.16mg/kg(对照或1组)、850mg/kg(2组)和1050mg/kg(3组)日粮7周。结果表明,后两组雏鸭分别于3周龄和2周龄开始出现临床症状,生长发育迟缓,并出现死亡;血红蛋白含量和红细胞数量显著低于对照组(p<0.05),红细胞变形、变性,大小不等;血清铜含量和肝铜含量极显著高于对照组(p<0.01)。     

一种新型微生态保健品在兽医临床中的应用研究

利用一种微生态保健品和3种抗菌素药物，即氟哌酸、氯霉素、庆大霉素在兽医临床上用于治疗仔猪黄白痢，断奶猪的应激性腹泻，肥猪及母猪的腹泻作了对比试验，结果表明：微生态保健品对仔猪黄痢的治愈率为93％，对仔猪白痢的治愈率为95％，对断奶仔猪的应激性腹泻治愈率为94％，对肥猪及母猪的腹泻治愈率为100％。与氟哌酸、庆大霉素的疗效比较，差异显著（P＜0．05）；与氯霉素比较差异极显著（P＜0．01）．     

西藏林芝临床型乳房炎的病因分析

本文从诊治的临床型乳房炎和奶牛生活环境入手，分析引起乳房炎的病因。调查显示有8种致病菌可引起乳房炎，统计分析了年龄、胎次与乳房炎的关系。建议结合当地实际情况采取科学的综合防制措施减少乳房炎的发生。     

The influence of fasting on blood glucose,triglycerides, cholesterol,and alkaline phosphatase in rats

Serum concentrations of glucose, cholesterol, triglycerides, and serum alkaline phosphatase activity were measured over different periods of time of food deprivation in male rats. Thirty percent of non-fasted rat's sera was found to be lipemic. At 16 hours of fasting, glucose levels dropped by 30% compared to the level of the non-fasting control group, and remained at a relatively constant level for up to 48 hours of fasting. Triglyceride concentrations decreased at 16 hours after fasting. Serum cholesterol levels were not changed at any of the fasting periods compared to the non-fasted control group. Alkaline phosphatase activity was decreased at 8 hours of fasting, with further declines in activity of the serum enzyme seen at 16, 24, and 48 hours of fasting. It was concluded that at 16 to 18 hours fasting, a non-absorptive state had been reached in male rats.     

Genetic variation among asexual progeny of Phytophthora infestans detected with RAPD and AFLP markers

Genotypic variation among 32 single-zoospore isolates (SZI) of Phytophthora infestans , derived asexually from two hyphal-tip parental isolates (PI-105 and PI-1) of the US-8 genotype, was assessed with 80 random amplified polymorphic DNA (RAPD) primers and 18 amplified fragment length polymorphic DNA (AFLP) primer pairs. In previous investigations, the SZIs from parental isolate PI-105 showed high levels of virulence variability and were differentiated into 14 races, whereas the SZIs from PI-1 showed identical virulence to the parent. The purpose of this investigation was to determine if phenotypic variation observed among SZIs of P. infestans could be detected at the DNA level in these isolates. Polymorphism was detected with 51 RAPD primers and with all 18 AFLP primer pairs in PI-105 SZIs. In SZIs from PI-1, polymorphism was also detected with 25 RAPD primers and 17 AFLP primer pairs. Cluster analysis using the unweighted pair-group method with arithmetic averages (UPGMA) separated the SZIs from parent PI-105 into six virulence groups, 11 RAPD groups and three AFLP groups. Cluster analysis of PI-1 SZIs, which all belong to the same virulence group, differentiated them into four RAPD groups and six AFLP groups. No close correlation among RAPD, AFLP and virulence groups could be established within the two progenies of SZIs. Results of this study suggest that there is a considerable level of inherent genetic variability among SZIs derived asexually from the same parental isolate. The possible mechanisms and implications of this genetic variation are discussed.     

Noninferiority trial investigating the efficacy of a nonantibiotic intramammary therapy in the treatment of mild‐to‐moderate clinical mastitis in dairy cows with longer lasting udder diseases

A nonblinded, positively controlled, noninferiority trial was conducted to evaluate the efficacy of an alternative, nonantibiotic therapy with Masti Veyxym^® to reduce ineffective antibiotic usage in the treatment of nonsevere clinical mastitis (CM) in cows with longer lasting udder diseases. The solely intramammary treatment with Masti Veyxym^® (three applications, 12 hr apart) and the combined treatment with Masti Veyxym^® and antibiotics as usual on the farm according to label of the respective product were compared with the reference treatment of solely antibiotic therapy. The matched field study was conducted on eight free‐stall dairy farms located in Eastern Germany. Cases of mild‐to‐moderate CM in cows with longer lasting high somatic cell counts in preceding dairy herd improvement test days and with previous CM cases in current lactation were randomly allocated to one of the three treatment groups. A foremilk sample of the affected quarter was taken before treatment and again approximately 14 days and 21 days after the end of therapy for cyto‐bacteriological examination. Primary outcomes were clinical cure (CC) and no CM recurrence within 60 days after the end of treatment (no R60). Bacteriological cure (BC) and quarter somatic cell count (QSCC) cure were chosen as secondary outcomes although low probabilities of BC and QSCC cure for selected cows were expected. The study resulted in the following findings: the pathogens mostly cultured from pretreatment samples were Streptococcus uberis, followed by Staphylococcus aureus and coagulase‐negative staphylococci. There were no significant differences between the two test treatments in comparison with the reference treatment regarding all outcome variables. The sole therapy with Masti Veyxym^® resulted in a numerically lower likelihood of BC without significant differences to the reference treatment. The combined therapy group showed a numerically higher nonrecurrence rate than the two other treatment groups and noninferiority compared to the reference treatment was proven. Having regard to the selection criteria of cows in this study, the findings indicated that sole treatment with Masti Veyxym^® in nonsevere CM cases may constitute an alternative therapy to reduce antibiotics. However, noninferiority evaluations were mostly inconclusive. Further investigations with a larger sample size are required to confirm the results and to make a clear statement on noninferiority.     

Investigation of Clinical Medicine for Treating Cows Endometritis in Baotou Area

In 4 dairy farms located in Baotou area, clinical medicine investigation and drug resistance of pathogenic bacteria were conducted, and then curative effects of different treatment methods were analyzed.Epidemic materials were collected from diary cows infected by endometritis, from which pathogenic bacteria were isolated using conventional microbiology technologies.Broth microdilution method was used to detect the sensitivity and resistance of pathogenic bacteria to antibiotics commonly used in clinic.On this basis, the sensitive drugs were used to treat mastitis or endometritis, the clinical curative effect of traditional treatment group was compared with that of therapeutic test group.The result of traditional treatment group showed 13 antibiotics were used to treat 160 cases of endometritis, florfenicol was most effective, penicillin was most ineffective.The results of therapeutic test group showed that Staphylococcus aureus, Escherichia coli and Streptococcus were the main pathogenic bacteria of endometritis, which were sensitive to gentamicin and cefalotin, etc.The results of statistical analysis showed that the curative effect of therapeutic test group was extremely significantly different from that of traditional treatment group(P<0.01).Sensitive drugs screened by drug sensitive test could be used to target therapy, and obtain satisfied curative effect.Moreover, this approach could avoid antibiotic abuse.     

烯丙孕素内服溶液的临床药效和靶动物安全性研究

研究国产烯丙孕素内服溶液的临床药效和靶动物安全性，为其新兽药注册和临床合理应用提供依据。通过发情间隔、发情率、发情集中度、妊娠率等指标评价烯丙孕素内服溶液调控母猪同期发情的临床效果；通过比较给药前后的临床体征、血常规指标、血清生化指标及组织病理学变化，评价烯丙孕素内服溶液对靶动物母猪的安全性。实验性临床试验中，国产烯丙孕素内服溶液高（25 mg·d-1）、中（20 mg·d-1）、低（10 mg·d-1）剂量组以及空白对照组的母猪从停药到出现发情反应的间隔时间分别为（3.45±0.81）（3.35±0.66）（5.21±2.65）和（11.71±5.39）d，发情率分别为100%（20/20）、100%（20/20）、95%（19/20）、70%（7/10）。扩大临床试验中，国产烯丙孕素内服溶液组和进口药物对照组的母猪在药物调控下均表现出良好的同期发情效果，发情间隔分别为（3.59±1.07）d和（3.75±1.22）d，发情率分别为96.72%（59/61）和98.33%（59/60）。靶动物安全性试验中，国产烯丙孕素内服溶液在5倍推荐剂量（100 mg·d-1）范围内对母猪的血液生理生化功能和主要脏器未造成明显的不良影响。结果表明，国产烯丙孕素内服溶液调控母猪同期发情，一次量20 mg，连续给药18 d，临床应用安全、有效。     

不同药物防治羔羊奶结症临床效果分析

为寻找羔羊奶结症的有效防治药物，将筛选出的5组药物用于羔羊奶结症的防治试验？结果表明，第l组药物“消维康”口服液对于减少羔羊奶结的发生有明显作用，第2组药物四仙莪棱香附散治疗羔羊奶结效果最佳．     

猫传染性腹膜炎研究进展

猫传染性腹膜炎是一种全身性、致死性的病毒性疾病,为幼猫和青年猫死亡的主要原因之一。近年来,该病在世界各地广泛流行,并呈一定的上升趋势。越来越多的学者对其进行了研究与探索,但其致病与免疫机制仍未完全清楚。本文从病原学、发病机制、流行病学、临床症状、诊断与治疗以及免疫与预防等方面对猫传染性腹膜炎进行全面的阐述,为该病的科学诊治与防控提供参考和指导。